COMMUNIQUÉS West-GlobeNewswire

-
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
26/04/2024 -
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
26/04/2024 -
The Ensign Group Schedules First Quarter Earnings Call for Thursday, May 2, 2024
26/04/2024 -
Composition of the Nomination Committee of Orion Corporation
26/04/2024 -
Medigene AG reports Financial Results and Business Update for Q1 2024
26/04/2024 -
PCI Biotech Holding ASA - Annual Report 2023
26/04/2024 -
Nexstim Plc Business Update Q1 2024
26/04/2024 -
Burning Rock Announces ADS Ratio Change
26/04/2024 -
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension
26/04/2024 -
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
26/04/2024 -
Belite Bio Announces $25 Million Registered Direct Offering
26/04/2024 -
Intuitive Announces Board of Directors Elections and Retirements
26/04/2024 -
Altimmune Statement on the Passing of Dr. Stephen Harrison
25/04/2024 -
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Decision from the Nasdaq Hearings Panel for Conditional Continued Listing
25/04/2024 -
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
25/04/2024 -
Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World
25/04/2024 -
Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update
25/04/2024 -
Combined General Meeting of May 16, 2024
25/04/2024 -
Assemblée Générale Mixte du 16 mai 2024
25/04/2024
Pages